Skip navigation

Monthly Archives: October 2016

The Arizona State University (ASU) Citizen Science and Maker Summit 2016  is an event hosted by ASU designed to explore the crossroads of citizen science, the maker movement and higher education. The summit is scheduled for October 26, 27 & 28, 2016 for downtown Chandler, Arizona at the ASU Chandler Innovation Center.

1000001 Labs participates in two related events:

1) Citizen Science Tools Database/Meta Data Workshop
2) Citizen Science and Maker Summit

The ASU Citizen Science Maker Summit 2016 will facilitate the sharing of best practices and help jump-start opportunities for the citizen science and making communities to learn from each other. The event will include a combination of breakout sessions, skill-building workshops and networking events, as well as multiple keynote speakers.

 

 

Summit highlights:

Explore best practices between makers and citizen scientists and learn how these two communities can benefit from each other.

Participate in multiple networking activities that allow you to connect with other conference attendees.

Engage in hands-on workshops conducted by TechShop staff and experience first hand what select machines can do. You will be able to take home what you make!

 

 

Here’s the agenda for the Summit.
 —
Date Local time

(US, Arizona)   

Event
Wednesday, October 26, 2016 6 pm – 7 pm Reception (optional)
Thursday, October 27, 2016 9 am – 5 pm Keynote address: David Lang, Founder of Open ROV
Keynote address: Alison Parker, EPA
Keynote address: Nancy Stoner, Pisces FoundationBreakout Sessions:
Data Quality in Federal Agencies
Maker to Manufacturing
Making Tools Discoverable (follow-up to Workshop)  
TechShopLightning talks
Birds of a Feather Un-conference session
Public Sharing and Ice Cream (optional)
Friday, October 28, 2016 8 am – 1 pm Keynote address: Heather Fleming, founder of Catapult
Design and Discuss
Sharing of Commitments
Lunch and TechShop time

 

Filip Velickovski presents his thesis on “clinical decision support for screening, diagnosis and assessment of respiratory diseases“, using “chronic obstructive pulmonary disease (COPD) as a use case”.

2016-10-06-11-02-08-1

The motivation behind the thesis is related to the negative impact of COPD on human society:
– COPD is caused by inhalation of irritants – mainly tobacco smoking;
– COPD is a respiratory disease characterized by non-reversible airflow limitation;
– airflow limitation is progressive.

(Cigarette smoking is responsible for more than 480,000 deaths per year in the United States alone, including nearly 42,000 deaths resulting from secondhand smoke exposure. This is about one in five deaths, or 1,300 deaths every day. On average, smokers die 10 years earlier than nonsmokers.)

 

Objectives of the thesis:

  • To achieve optimal clinical decision support system (CDSS) design to support healthcare providers with early-stage COPD detection
  • To develop reasoning methods and algorithms for decision support tasks in COPD management
  • To develop algorithms for quality assurance of spirometry
  • To validate the algorithms against expert clinical professionals

 

Conclusions of the thesis:

  • High prevalence + under-diagnosis of COPD cause a high burden in non-specialist settings
  • CDSS as a complementary service to integrated care of chronic patients
  • CDSS into healthcare providers work-flow
  • Rule-based and data-driven methods to support screening, case-finding, and diagnosis
  • Evaluations of these methods show performance near the level of clinical expert
  • Credible potential to assist non-specialist healthcare providers

 

Summary of the contributions of the thesis:

  • A CDSS framework that includes:
    • Adapted incremental software development model
    • Reasoning paradigm
    • Suite of decision support services
  • Extension to the HL7 virtual medical record (VMR) for the representation of COPD concepts allowing & enabling interoperability
  • Software architecture model facilitating CDSS services to be integrated to existing health information systems (HISs)
  • COPD guidelines ’ representation through rules benchmarked against clinical experts
  • 28 new rules using 23 novel metrics assuring quality of spirometry by targeting 5 curve zones
  • Multi-expert model of spirometry QA using ML
  • Quality assurance approaches validated using three experts

 

Future work:

  • Expand CDSS capabilities
    • Personalised treatment recommendations
    • Exacerbation prognosis
    • Issue recommendations for specific integrated care programs
  • Classification of rejected spirometry
  • Evaluate CDSS for COPD in pilot trial
  • Adapt the CDSS framework to other non-communicable diseases (NCDs), such as diabetes and heart disease, and to the case of co-morbid patients

2016-10-06-11-54-56-1